SEC Form 4 · accession 0001387131-16-005678
Ohr Pharmaceutical Inc · OHRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Samuel Backenroth
Officer — Chief Financial Officer
Period of report
May 23, 2016
Accepted (ET)
May 24, 2016 · 12:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001173281
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share | May 23, 2016 | P | 163 | $3.23 | A | 136,362 | D | |
| Common Stock, par value $0.0001 per share | May 23, 2016 | P | 11 | $3.22 | A | 136,373 | D | |
| Common Stock, par value $0.0001 per share | May 23, 2016 | P | 184 | $3.21 | A | 136,557 | D | |
| Common Stock, par value $0.0001 per share | May 23, 2016 | P | 54 | $3.20 | A | 136,611 | D | |
| Common Stock, par value $0.0001 per share | May 23, 2016 | P | 152 | $3.19 | A | 136,763 | D | |
| Common Stock, par value $0.0001 per share | May 23, 2016 | P | 192 | $3.18 | A | 136,955 | D | |
| Common Stock, par value $0.0001 per share | May 23, 2016 | P | 834 | $3.17 | A | 137,789 | D | |
| Common Stock, par value $0.0001 per share | May 23, 2016 | P | 379 | $3.16 | A | 138,168 | D | |
| Common Stock, par value $0.0001 per share | May 23, 2016 | P | 184 | $3.15 | A | 138,352 | D | |
| Common Stock, par value $0.0001 per share | May 23, 2016 | P | 43 | $3.14 | A | 138,395 | D | |
| Common Stock, par value $0.0001 per share | May 23, 2016 | P | 97 | $3.13 | A | 138,492 | D | |
| Common Stock, par value $0.0001 per share | May 23, 2016 | P | 11 | $3.125 | A | 138,503 | D | |
| Common Stock, par value $0.0001 per share | May 23, 2016 | P | 163 | $3.12 | A | 138,666 | D | |
| Common Stock, par value $0.0001 per share | May 23, 2016 | P | 33 | $3.11 | A | 138,699 | D |
Table II — derivative securities
No Table II lines on this filing.